Melatonin, a potent agent in antioxidative defense: Actions as a natural food constituent, gastrointestinal factor, drug and prodrug

Nutrition and Metabolism

Volumn 2, Issue , 2005, Pages

  Hardeland, Rüdiger ^a   Pandi Perumal, S R ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 2; FOOD ADDITIVE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; HYDROXYL RADICAL; KYNURAMINE; MANGANESE SUPEROXIDE DISMUTASE; MELATONIN; N 1 ACETYL 5 METHOXYKYNURAMINE; N 1 ACETYL N 2 FORMYL 5 METHOXYKYNURAMINE; PRODRUG; REACTIVE NITROGEN SPECIES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ASSAY; CHEMICAL INTERACTION; CHEMOLUMINESCENCE; CIRCADIAN RHYTHM; CIRCULATION; DETOXIFICATION; DIET; DNA MODIFICATION; DOSE RESPONSE; DOWN REGULATION; DROWSINESS; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; ENZYME INHIBITION; FOOD ANALYSIS; FOOD COMPOSITION; FOOD INTAKE; FRUIT; GASTROINTESTINAL TRACT; GLUTATHIONE METABOLISM; HORMONE RELEASE; HUMAN; IC 50; INTRACELLULAR SPACE; MITOCHONDRIAL RESPIRATION; NERVE CELL; NONHUMAN; NUTRIENT; NUTRITIONAL VALUE; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHOTOCATALYSIS; PINEAL BODY; REVIEW; SIDE EFFECT; STOICHIOMETRY; ULTRAVIOLET RADIATION; UPREGULATION; VEGETABLE; YEAST;

EID: 26844450246     PISSN: 17437075     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-2-22     Document Type: Review

References (162)

1. Arendt J, Deacon S: Treatment of circadian rhythm disorders - melatonin. Chronobiol Int 1997, 14:185-204.
2. Arendt J: Jet-lag. Lancet 1998, 351:293-294.
3. Herxheimer A, Waterhouse J: The prevention and treatment of jet lag. Br Med J 2003, 326:296-297.
4. Oxenkrug GF, Requintina PJ: Melatonin and jet lag syndrome: experimental model and clinical applications. CNS Spectr 2003, 8:139-148.
5. Reiter RJ: Oxidative damage in the central nervous system: Protection by melatonin. Prog Neurobiol 1998, 56:359-384.
6. Reiter RJ, Tan D-X, Cabrera J, D'Arpa D, Sainz RM, Mayo JC, Ramos S: The oxidation/antioxidant network: role of melatonin. Biol Signals Recept 1999, 8:56-63.
7. Reiter RJ, Tan D-X, Osuna C, Gitto E: Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 2000, 7:444-458.
8. Reiter RJ, Tan D-X, Burkhardt S, Manchester LC: Melatonin in plants. Nutr Rev 2001, 59:286-290.
9. Reiter RJ, Tan D-X, Burkhardt S: Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech Ageing Dev 2002, 123:1007-1019.
10. Reiter RJ, Tan D-X, Mayo JC, Sainz RM, Leon J, Czarnocki Z: Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 2003, 50:1129-1146.
11. Pappolla MA, Chyan Y-J, Poeggeler B, Frangione B, Wilson G, Ghiso J, Reiter RJ: An assessment of the antioxidant and antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J Neural Transm 2000, 107:203-231.
12. Cardinali DP, Brusco LI, Liberczuk C, Furio AM: The use of melatonin in Alzheimer's disease. Neuroendocrinol Lett 2002, 23(Suppl 1):20-23.
13. Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ: A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 2003, 26:893-901.
14. Jacob S, Poeggeler B, Weishaupt JH, Sirén A-L, Hardeland R, Bähr M, Ehrenreich H: Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): High tolerability of daily oral melatonin administration in ALS patients. J Pineal Res 2002, 33:186-187.
15. Hardeland R, Fuhrberg B: Ubiquitous melatonin - Presence and effects in unicells, plants and animals. Trends Comp Biochem Physiol 1996, 2:25-45.
16. Hardeland R: Melatonin and 5-methoxytryptamine in nonmetazoans. Reprod Nutr Dev 1999, 39:399-408.
17. Hardeland R, Poeggeler B: Non-vertebrate melatonin. J Pineal Res 2003, 34:233-241.
18. Dubbels R, Reiter RJ, Klenke E, Goebel A, Schnakenberg E, Ehlers C, Schiwara HP, Schloot W: Melatonin in edible plants identified by radioimmunoasay and by high performance liquid-chromatography-mass spectrometry. J Pineal Res 1995, 18:28-31.
19. Hattori A, Migitaka H, Iigo M, Itoh M, Yamamoto K, Ohtani-Kaneko R, Hara M, Suzuki T, Reiter RJ: Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem Mol Biol Int 1995, 35:627-634.
20. Balzer I, Hardeland R: Melatonin in algae and higher plants - Possible new roles as a phytohormone and antioxidant. Bot Acta 1996, 109:180-183.
21. Van Tassel DL, O'Neill SD: Putative regulatory molecules in plants: evaluating melatonin. J Pineal Res 2001, 31:1-7.
22. Van Tassel DL, Roberts N, Lewy A, O'Neill SD: Melatonin in plant organs. J Pineal Res 2001, 31:8-15.
23. Burkhardt S, Tan DX, Manchester LC, Hardeland R, Reiter RJ: Detection and quantification of the antioxidant melatonin in Montmorency and Balaton tart cherries (Prunus cerasus). J Agric Food Chem 2001, 49:4898-4902.
24. Reiter RJ, Tan D-X: Melatonin: an antioxidant in edible plants. Ann NY Acad Sci 2002, 957:341-344.
25. Conti A, Tettamanti C, Singaravel M, Haldar C, Pandi-Perumal RS, Maestroni GJM: Melatonin: An ubiquitous and evolutionary hormone. In Treatise on Pineal Gland and Melatonin Edited by: Haldar C, Singaravel M, Maitra SK. Enfield, NH: Science Publishers; 2002:105-143.
26. Poeggeler B, Hardeland R: Detection and quantification of melatonin in a dinoflagellate, Gonyaulax polyedra. Solutions to the problem of methoxyindole destruction in non-vertebrate material. J Pineal Res 1994, 17:1-10.
27. Murch SJ, Simmons CB, Saxena PK: Melatonin in fever few and other medicinal plants. Lancet 1997, 350:1598-1599.
28. Manchester LC, Tan D-X, Reiter RJ, Park W, Monis K, Qi W: High levels of melatonin in the seeds of edible plants. Possible function in germ tissue protection. Life Sci 2000, 67:3023-3029.
29. Sprenger J, Hardeland R, Fuhrberg B: Methoxyindoles in yeast: Variability and effects of growth conditions. In Biological Rhythms and Antioxidative Protection Edited by: Hardeland R. Göttingen: Cuvillier; 1997:116-118.
30. Sprenger J, Hardeland R, Fuhrberg B, Han S-Z: Melatonin and other 5-methoxylated indoles in yeast: Presence in high concentrations and dependence on tryptophan availability. Cytologia 1999, 64:209-213.
31. Balzer I, Höcker B, Kapp H, Bartolomaeus B: Occurrence and comparative physiology of melatonin in evolutionary diverse organisms. In The Redox State and Circadian Rhythms Edited by: Vanden Driessche T, Guisset J-L, Petiau-de Vries GM. Boston - London: Kluwer; 2000:95-119.
32. Huether G, Poeggeler B, Reimer A, George A: Effect of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci 1992, 51:945-53.
33. Huether G: The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia 1993, 49:665-670.
34. Hardeland R: Melatonin: Multiple functions in signaling and protection. In Skin Cancer and UV Radiation Edited by: Altmeyer P, Hoffmann K, Stücker M. Berlin - Heidelberg: Springer; 1997:186-198.
35. Bubenik GA: Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept 2001, 10:350-366.
36. Bubenik GA: Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002, 47:2336-2348.
37. Messner M, Hardeland R, Rodenbeck A, Huether G: Tissue retention and subcellular distribution of continuously infused melatonin in rats under near physiological conditions. J Pineal Res 1998, 25:251-259.
38. Bubenik GA, Hacker RR, Brown GM, Bartos L: Melatonin concentrations in the luminal fluid, mucosa and muscularis of the bovine and porcine gastrointestinal tract. J Pineal Res 1999, 26:56-63.
39. Tan D-X, Manchester LC, Reiter RJ, Qi W, Hanes MA, Farley NJ: High physiological levels of melatonin in the bile of mammals. Life Sci 1999, 65:2523-2529.
40. Tan D-X, Manchester LC, Hardeland R, Lopez-Burillo S, Mayo JC, Sainz RM, Reiter RJ: Melatonin - a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003, 34:75-78.
41. 2-formyl- 5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001, 15:2294-2296.
42. 2-formyl-5- methoxykynuramine, resveratrol and uric acid. Int J Biochem Cell Biol 2001, 33:775-783.
43. 1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep 2003, 8:205-213.
44. Hardeland R, Poeggeler B, Balzer B, Behrmann G: Common basis of photoperiodism in phylogenetically distant organisms and its possible origins. J Interdiscipl Cycle Res 1991, 22:122-123.
45. Hardeland R, Poeggeler B, Balzer I, Behrmann G: A hypothesis on the evolutionary origins of photoperiodism based on circadian rhythmicity of melatonin in phylogenetically distant organisms. In Chronobiology & Chronomedicine Gutenbrunner C, Hildebrandt G, Moog R. Frankfurt: Lang; 1993:113-120.
46. 2-formyl-5-methoxykynuramine. Sleep Res 1993, 22:621.
47. Tan D-X, Chen L-D, Poeggeler B, Manchester LC, Reiter RJ: Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993, 1:57-60.
48. Reiter RJ, Poeggeler B, Tan D-X, Chen L-D, Manchester LC, Guerrero JM: Antioxidant capacity of melatonin: A novel action not requiring a receptor. Neuroendocrinol Lett 1993, 15:103-116.
49. Hardeland R, Reiter RJ, Poeggeler B, Tan D-X: The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 1993, 17:347-357.
50. Poeggeler B, Reiter RJ, Hardeland R, Sewerynek E, Melchiorri D, Barlow-Walden LR: Melatonin, a mediator of electron transfer and repair reactions, acts synergistically with the chain-breaking antioxidants ascorbate, trolox and glutathione. Neuroendocrinol Lett 1995, 17:87-92.
51. Poeggeler B, Reiter RJ, Hardeland R, Tan D-X, Barlow-Walden LR: Melatonin and structurally-related, endogenous indoles act as potent electron donors and radical scavengers in vitro. Redox Rep 1996, 2:179-184.
52. Poeggeler B, Thuermann S, Dose A, Schoenke M, Burkhardt S, Hardeland R: Melatonin's unique radical scavenging properties - Roles of its functional substituents as revealed by a comparison with its structural analogs. J Pineal Res 2002, 33:20-30.
53. Poeggeler B, Saarela S, Reiter RJ, Tan D-X, Chen L-D, Manchester LC, Barlow-Walden LR: Melatonin - a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro. Ann NY Acad Sci 1994, 738:419-420.
54. Matuszak Z, Reszka KJ, Chignell CF: Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Radic Biol Med 1997, 23:367-372.
55. Stasica P, Ulanski P, Rosiak JM: Reactions of melatonin with radicals in deoxygenated aqueous solution. J Radioanal Nucl Chem 1998, 232:107-113.
56. Chyan Y-J, Poeggeler B, Omar RA, Chain DG, Frangione B, Ghiso J, Pappolla MA: Potent neuroprotective properties against the Alzheimer β-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J Biol Chem 1999, 274:21937-21942.
57. Mahal HS, Sharma HS, Mukherjee T: Antioxidant properties of melatonin: a pulse radiolysis study. Free Radic Biol Med 1999, 26:557-565.
58. Hardeland R, Niebergall R, Schoenke M, Poeggeler B: Carbonate radicals as initiators of melatonin oxidation: Chemiluminescence and formation of oxidation products. In Actions and Redox Properties of Melatonin and Other Aromatic Amino Acid Metabolites Edited by: Hardeland R. Göttingen: Cuvillier; 2001:49-55.
59. Hardeland R, Poeggeler B, Burkhardt S, Zelosko V, Niebergall R, Tomás-Zapico C, Thuermann S, Schoenke M, Dose A, Gruetzner T, Coto-Montes A: Oxidation chemistry of melatonin: New aspects of radical reactions. In Neuroendocrine System and Pineal Gland with Special Reference to Lifestock Edited by: Haldar C, Singh SS. Varanasi: Banaras Hindu University; 2003:27-35.
60. Hardeland R, Poeggeler B, Niebergall R, Zelosko V: Oxidation of melatonin by carbonate radicals and chemiluminescence emitted during pyrrole ring cleavage. J Pineal Res 2003, 34:17-25.
61. Uría H, Fuhrberg B, Poeggeler B, Hardeland R, Menéndez- Peláez A: Photooxidation of melatonin. In Cell Biological Problems in Chronobiology Edited by: Hardeland R. Göttingen: University of Göttingen; 1994:89-99.
62. Hardeland R, Balzer I, Poeggeler B, Fuhrberg B, Uría H, Behrmann G, Wolf R, Meyer TJ, Reiter RJ: On the primary functions of melatonin in evolution: Mediation of photoperiodic signals in a unicell, photooxidation and scavenging of free radicals. J Pineal Res 1995, 18:104-111.
63. Cagnoli CM, Atabay C, Kharlamova E, Manev H: Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res 1995, 18:222-226.
64. Matuszak Z, Bilska MA, Reszka KJ, Chignell CF, Bilski P: Interaction of singlet molecular oxygen with melatonin and related indoles. Photochem Photobiol 2003, 78:449-455.
65. 2-formyl- 5-methoxykynuramine = AFMK, not the corresponding kynurenine.
66. Burkhardt S, Poeggeler B, Tan D-X, Rosner C, Gruetzner T, Nitzki F, Schoenke M, Thuermann S, Reiter RJ, Hardeland R: Oxidation products formed from melatonin in various radical-generating systems. In Actions and Redox Properties of Melatonin and Other Aromatic Amino Acid Metabolites Edited by: Hardeland R. Göttingen: Cuvillier; 2001:9-22.
67. 2-formyl-5-methoxykynuramine formation from melatonin. In Actions and Redox Properties of Melatonin and Other Aromatic Amino Acid Metabolites Edited by: Hardeland R. Göttingen: Cuvillier; 2001:136-141.
68. Tan D-X, Hardeland R, Manchester LC, Poeggeler B, Lopez-Burillo S, Mayo JC, Sainz RM, Reiter RJ: Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J Pineal Res 2003, 34:249-259.
69. Tan D-X, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, Mayo JC, Kohen R, Allegra M, Hardeland R: Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002, 2:181-197.
70. Tan D-X, Manchester LC, Reiter RJ, Plummer BF, Hardies LJ, Weintraub ST, Vijayalaxmi , Shepherd AMM: A novel melatonin metabolite, cyclic 3-hydroxymelatonin: A biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998, 253:614-620.
71. Stasica P, Paneth P, Rosiak JM: Hydroxyl radical reaction with melatonin molecule: a computational study. J Pineal Res 2000, 29:125-127.
72. Agozzino P, Avellone G, Bongiorno D, Ceraulo L, Filizzola F, Natoli MC, Livrea MA, Tesoriere L: Melatonin: structural characterization of its non-enzymatic mono-oxygenate metabolite. J Pineal Res 2003, 35:269-275.
73. Turjanski AG, Chaia Z, Rosenstein RE, Estrin DA, Doctorovich F, Piro O: N-nitrosomelatonin. Acta Crystallogr 2000, C56:682-683.
74. Turjanski AG, Leonik F, Rosenstein RE, Estrin DA, Doctorovich F: Scavenging of NO by melatonin. J Am Chem Soc 2000, 122:10468-10469.
75. Turjanski AG, Saenz DA, Doctorovich F, Estrin DA, Rosenstein RE: Nitrosation of melatonin by nitric oxide: a computational study. J Pineal Res 2001, 31:97-101.
76. Tesoriere L, Avellone G, Ceraulo L, D'Arpa D, Allegra M, Livrea MA: Oxidation of melatonin by oxoferryl hemoglobin: a mechanistic study. Free Radic Res 2001, 35:633-642.
77. Hardeland R, Coto-Montes A, Poeggeler B: Circadian rhythms, oxidative stress and antioxidative defense mechanisms. Chronobiol Int 2003, 20:921-962.
78. Hardeland R, Poeggeler B: Melatonin: New aspects of its protective actions and novel metabolites. In Experimental Endocrinology and Reproductive Biology Edited by: Haldar C, Singaravel M, Pandi-Perumal SR, Cardinali DP. Enfield, NH: Science Publishers; 2005 in press.
79. Blanchard B, Pompon D, Ducrocq C: Nitrosation of melatonin by nitric oxide and peroxynitrite. J Pineal Res 2000, 29:184-192.
80. Reiter RJ, Tan D-X, Manchester LC, Qi W: Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001, 34:237-256.
81. Reiter RJ, Tan D-X, Manchester LC, Lopez-Burillo S, Sainz RM, Mayo JC: Melatonin: detoxification of oxygen and nitrogen-based toxic reactants. Adv Exp Med Biol 2003, 527:53-548.
82. Blanchard-Fillion B, Servy C, Ducrocq C: 1-Nitrosomelatonin is a spontaneous NO-releasing compound. Free Radic Res 2001, 35:857-866.
83. Hardeland R, Saverschek N: The NO adduct of spin trap TMAPTIO [= 2-(trimethylammonio-phenyl)-4, 4, 5, 5-tetramethyl-imidazoline-1-oxyl-3-oxide] acts as an NO donor and stimulator of nitrosation reactions. In Actions and Redox Properties of Melatonin and Other Aromatic Amino Acid Metabolites Edited by: Hardeland R. Göttingen, Germany: Cuvillier; 2001:131-135.
84. Zhang H, Squadrito GL, Uppu R, Pryor WA: Reaction of peroxynitrite with melatonin: a mechanistic study. Chem Res Toxicol 1999, 12:626-534.
85. Zhang H, Squadrito GL, Pryor WA: The reaction of melatonin with peroxynitrite: formation of melatonin radical cation and absence of stable nitrated products. Biochem Biophys Res Commun 1998, 251:83-87.
86. Cimen B, Turkozkan N, Unlu A, Erbil MK: Effects of melatonin on 3-nitrotyrosine formation and energy charge ratio in guinea pig kidney in LPS-induced stress. Cell Biochem Funct 2005, 23:273-277.
87. Gitto E, Tan D-X, Reiter RJ, Karbownik M, Manchester LC, Cuzzocrea S, Fulia F, Berberi I: Individual and synergistic antioxidative actions of melatonin: studies with vitamin E, vitamin C, glutathione and desferrioxamine (desferoxamine) in rat liver homogenates. J Pharm Pharmacol 2001, 53:1393-1401.
88. Balkan J, Sener G, Cevikbas U, Keyser-Uysal M, Uysal M: Melatonin improved the disturbances in hepatic prooxidant and antioxidant balance and hepatotoxicity induced by a cholesterol diet in C57BL/6J mice. Int J Vitam Nutr Res 2004, 74:349-254.
89. Hardeland R, Ressmeyer A-R, Zelosko V, Burkhardt S, Poeggeler B: Metabolites of melatonin: Formation and properties of the methoxylated kynuramines AFMK and AMK. In Recent Advances in Endocrinology and Reproduction: Evolutionary, Biotechnological and Clinical Applications Edited by: Haldar C, SS Singh SS. Varanasi: Banaras Hindu University; 2004:21-38.
90. Poeggeler B, Hardeland R: Observations on melatonin oxidation and metabolite release by unicellular organisms and small aquatic metazoans. In Actions and Redox Properties of Melatonin and Other Aromatic Amino Acid Metabolites Edited by: Hardeland R. Göttingen: Cuvillier; 2001:66-69.
91. Ferry G, Ubeaud C, Lambert PH, Bertin S, Cogé F, Chomarat P, Delagrange P, Serkiz B, Bouchet JP, Truscott RJ, Boutin JA: Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan. Investigation on both indoleamine-2, 3-dioxygenase and myeloperoxidase. Biochem J 2005, 388(Pt. 1):205-215.
92. Hirata F, Hayaishi O, Tokuyama T, Senoh S: In vitro and in vivo formation of two new metabolites of melatonin. J Biol Chem 1974, 249:1311-1313.
93. Alberati-Giani D, Ricciardi-Castagnoli P, Köhler C, Cesura AM: Regulation of the kynurenine pathway by IFN-. in murine cloned macrophages and microglial cells. Adv Exp Med Biol 1966, 398:171-175.
94. Lestage J, Verrier D, Palin K, Dantzer R: The enzyme indoleamine 2, 3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav Immun 2002, 16:596-601.
95. Kwidzinski E, Bunse J, Kovac AD, Ullrich O, Zipp F, Nitsch R, Bechmann U: IDO (indolamine 2, 3-dioxygenase) expression and function in the CNS. Adv Exp Med Biol 2003, 527:113-118.
96. Ximenes VF, Catalani LH, Campa A: Oxidation of melatonin and tryptophan by an HRP cycle involving compound III. Biochem Biophys Res Commun 2001, 287:130-134.
97. Rodrigues MR, Rodriguez D, Catalani LH, Russo M, Campa A: Interferon-gamma independent oxidation of melatonin by macrophages. J Pineal Res 2003, 34:69-74.
98. Tan D-X, Manchester LC, Reiter RJ, Qi W-B, Karbownik M, Calvo JR: Significance of melatonin in antioxidative defense system: Reactions and products. Biol Signals Recept 2000, 9:137-159.
99. Balzer I, Hardeland R: Action of kynuramine in a dinoflagellate: stimulation of bioluminescence in Gonyaulax polyedra. Comp Biochem Physiol 1989, 94C:129-132.
100. Behrends A, Hardeland R, Ness H, Grube S, Poeggeler B, Haldar C: Photocatalytic actions of the pesticide metabolite 2-hydroxyquinoxaline: destruction of antioxidant vitamines and biogenic amines - implications of organic redox cycling. Redox Rep 2004, 9:279-288.
101. Kelly RW, Amato F, Seamark RF: N-Acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesis. Biochem Biophys Res Commun 1984, 121:372-379.
102. Mayo JC, Sainz RM, Tan D-X, Hardeland R, Leon J, Rodriguez C, Reiter RJ: Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl- 5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 2005, 165:139-149.
103. 1-acetyl-5-methoxykynuramine) with reactive nitrogen species: Formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK. J Pineal Res 2005. online ahead publ.: DOI 10.1111/j.1600-079X. 2005.00242.x
104. Barlow-Walden LR, Reiter RJ, Abe M, Pablos M, Menendez-Pelaez A, Chen LD, Poeggeler B: Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995, 26:497-502.
105. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acuña-Castroviejo D: A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995, 18:1-11.
106. Pablos MI, Agapito MT, Gutierrez R, Recio JM, Reiter RJ, Barlow-Walden L, Acuña-Castroviejo D, Menendez-Pelaez A: Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res 1995, 19:111-115.
107. Pablos MI, Chuang J, Reiter RJ, Ortiz GG, Daniels WM, Sewerynek E, Melchiorri D, Poeggeler B: Time course of the melatonin-induced increase in glutathione peroxidase activity in chick tissues. Biol Signals 1995, 4:325-30.
108. Reiter RJ, Garcia JJ, Pie J: Oxidative toxicity in models of neuro-degeneration: responses to melatonin. Restor Neurol Neurosci 1998, 12:135-42.
109. Kotler M, Rodríguez C, Sáinz RM, Antolín I, Menéndez-Peláez A: Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 1998, 24:83-89.
110. Ustundag B, Kazez A, Demirbag M, Canatan H, Halifeoglu I, Ozercan IH: Protective effect of melatonin on antioxidative system in experimental ischemia-reperfusion of rat small intestine. Cell Physiol Biochem 2000, 10:229-236.
111. Okatani Y, Wakatsuki A, Kaneda C: Melatonin increases activities of glutathione peroxidase and superoxide dismutase in fetal rat brain. J Pineal Res 2000, 28:89-96.
112. Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S: Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann NY Acad Sci 2001, 939:200-215.
113. Wakatsuki A, Okatani Y, Shinohara K, Ikenoue N, Kaneda C, Fukaya T: Melatonin protects fetal rat brain against oxidative mitochondrial damage. J Pineal Res 2001, 30:22-28.
114. Gürdöl F, Genç S, Öner-Ýyidogan Y, Süzme R: Coadministration of melatonin and estradiol in rats: effects on oxidant status. Horm Metab Res 2001, 33:608-611.
115. Okatani Y, Wakatsuki A, Shinohara K, Kaneda C, Fukaya T: Melatonin stimulates glutathione peroxidase activity in human chorion. J Pineal Res 2001, 30:199-205.
116. Okatani Y, Wakatsuki A, Reiter RJ: Melatonin protects hepatic mitochondrial respiratory chain activity in senescence-accelerated mice. J Pineal Res 2002, 32:143-148.
117. Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, Rodriguez C: Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 2002, 59:1706-1713.
118. Gómez M, Esparza JL, Nogués MR, Giralt M, Cabré M, Domingo JL: Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radic Biol Med 2005, 38:104-111.
119. Liu F, Ng TB: Effect of pineal indoles on activities of the antioxidant defense enzymes superoxide dismutase, catalase, and glutathione reductase, and levels of reduced and oxidized glutathione in rat tissues. Biochem Cell Biol 2000, 78:447-453.
120. Antolín I, Rodríguez C, Sáinz RM, Mayo JC, Uría H, Kotler ML, Rodríguez-Colunga MJ, Tolivia D, Menéndez-Peláez A: Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J 1996, 10:882-890.
121. Öztürk G, Coşkun S, Erbaş D, Hasanoǧlu E: The effect of melatonin on liver superoxide dismutase activity, serum nitrate and thyroid hormone levels. Jap J Physiol 2000, 50:149-153.
122. Wang H, Wei W, Shen YX, Dong C, Zhang LL, Wang NP, Yue L, Xu SY: Protective effect of melatonin against liver injury in mice induced by Bacillus Calmette-Guerin plus lipopolysaccharide. World J Gastroenterol 2004, 10:2690-2696.
123. Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, Martín V, Reiter RJ: Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004, 36:1-9.
124. Tomás-Zapico C, Coto-Montes A, Martínez-Fraga J, Rodríguez-Colunga MJ, Hardeland R, Tolivia D: Effects of δ-aminolevulinic acid and melatonin in the Harderian gland of female Syrian hamster. Free Radic Biol Med 2002, 32:1197-1204.
125. Erten SF, Kocak A, Ozdemir I, Aydemir S, Colak A, Reeder BS: Protective effect of melatonin on experimental spinal cord ischemia. Spinal Cord 2003, 41:533-538.
126. Uz T, Manev H: Circadian expression of pineal 5-lipoxygenase mRNA. Neuroreport 1998, 9:783-786.
127. Manev H, Uz T, Qu T: Early upregulation of hippocampal 5-lipoxygenase following systemic administration of kainate to rats. Restor Neurol Neurosci 1998, 12:81-85.
128. Zhang H, Akbar M, Kim HY: Melatonin: an endogenous negative modulator of 12-lipoxygenation in the rat pineal gland. Biochem J 1999, 344(Pt. 2):487-493.
129. Pozo D, Reiter RJ, Calvo JR, Guerrero JM: Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci 1994, 55:PL455-PL460.
130. Bettahi I, Pozo D, Osuna C, Reiter RJ, Acuña-Castroviejo D, Guerrero JM: Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 1996, 20:205-210.
131. Gilad E, Wong HR, Zingarelli B, Virag L, O'Connor M, Salzman AL, Szabo C: Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibitions of NFκB activation. FASEB J 1998, 12:685-693.
132. Chang HM, Ling EA, Chen CF, Lue H, Wen CY, Shieh JY: Melatonin attenuates the neuronal NADPH-d/NOS expression in the nodose ganglion of acute hypoxic rats. J Pineal Res 2002, 32:65-73.
133. Rogério F, de Souza Queiroz L, Teixeira SA, Oliveira AL, de Nucci G, Langone F: Neuroprotective action of melatonin on neonatal rat motoneurons after sciatic nerve transection. Brain Res 2002, 926:33-41.
134. Storr M, Koppitz P, Sibaev A, Saur D, Kurjak M, Franck H, Schusdziarra V, Allescher HD: Melatonin reduces non-adrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro. J Pineal Res 2002, 33:101-108.
135. Nosjean O, Ferro M, Cogé F, Beauverger P, Henlin J-M, Lefoulon F, Fauchère J-L, Delagrange P, Canet E, Boutin JA: Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 2000, 275:31311-31317.
136. Nosjean O, Nicolas JP, Klupsch F, Delagrange P, Canet E, Boutin JA: Comparative parmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2. Biochem Pharmacol 2001, 61:1369-1379.
137. Coto-Montes A, Hardeland R: Diurnal rhythm of protein carbonyl as an indicator of oxidative damage in Drosophila melanogaster: Influence of clock gene alleles and deficiencies in the formation of free-radical scavengers. Biol Rhythm Res 1999, 30:383-391.
138. Coto-Montes A, Tomás-Zapico C, Rodríguez-Colunga MJ, Tolivia-Cadrecha D, Martínez-Fraga J, Hardeland R, Tolivia D: Effects of the circadian mutation 'tau' on the Harderian glands of Syrian hamsters. J Cell Biochem 2001, 83:426-434.
139. Sharman EH, Bondy SC: Effects of age and dietary antioxidants on cerebral electron transport chain activity. Neurobiol Aging 2001, 22:629-634.
140. Okatani Y, Wakatsuki A, Reiter RJ, Miyahara Y: Hepatic mitochondrial dysfunction in senescence-accelerated mice: correction by long-term, orally administered physiological levels of melatonin. J Pineal Res 2002, 33:127-133.
141. Martín M, Macías M, León J, Escames G, Khaldy H, Acuña-Castroviejo D: Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int J Biochem Cell Biol 2002, 34:348-357.
142. Acuña-Castroviejo D, Martin M, Macias M, Escames G, Leon J, Khaldy H, Reiter RJ: Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res 2001, 30:65-74.
143. Escames G, León J, Macías M, Khaldy H, Acuña- Castroviejo D: Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats. FASEB J 2003, 17:932-934.
144. Okatani Y, Wakatsuki A, Reiter RJ, Enzan H, Miyahara Y: Protective effect of melatonin against mitochondrial injury induced by ischemia and reperfusion of rat liver. Eur J Pharmacol 2003, 469:145-152.
145. Watanabe K, Wakatsuki A, Shinohara K, Ikenoue N, Yokota K, Fukaya T: Maternally administered melatonin protects against ischemia and reperfusion-induced oxidative mitochondrial damage in premature fetal rat brain. J Pineal Res 2004, 37:276-280.
146. León J, Acuña-Castroviejo D, Escames G, Tan D-X, Reiter RJ: Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005, 38:1-9.
147. Acuña-Castroviejo D, Escames G, León J, Carazo A, Khaldy H: Mitochondrial regulation by melatonin and its metabolites. Adv Exp Med Biol 2003, 527:549-557.
148. Yalcin A, Kilinc E, Kocturk S, Resmi H, Sozmen EY: Effect of melatonin cotreatment against kainic acid on coenzyme Q10, lipid peroxidation and Trx mRNA in rat hippocampus. Int J Neurosci 2004, 114:1085-1097.
149. Martín M, Macías M, Escames G, Reiter RJ, Agapito MT, Ortiz GG, Acuña-Castroviejo D: Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res 2000, 28:242-248.
150. León J, Acuña-Castroviejo D, Sáinz RM, Mayo JC, Tan D-X, Reiter RJ: Melatonin and mitochondrial function. Life Sci 2004, 75:765-790.
151. Okatani Y, Wakatsuki A, Reiter RJ, Miyahara Y: Acutely administered melatonin restores hepatic mitochondrial physiology in old mice. Int J Biochem Cell Biol 2003, 35:367-375.
152. Genova ML, Merlo Pich M, Bernacchia A, Bianchi C, Biondi A, Bovina C, Falasca AI, Formiggini G, Parenti Castelli G, Lenaz G: The mitochondrial
153. Jou M-J, Peng T-I, Reiter RJ, Jou S-B, Wu H-Y, Wen S-T: Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res 2004, 37:55-70.
154. Andrabi SA, Sayeed I, Siemen D, Wolf G, Horn TF: Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J 2004, 18:869-871.
155. Xu M, Ashraf M: Melatonin protection against lethal myocyte injury induced by doxorubicin as reflected by effects on mitochondrial membrane potential. J Mol Cell Cardiol 2002, 34:75-79.
156. Poeggeler B: Neuroprotection by indole and nitrone compounds acting as mitochondrial metabolism modifiers with potent antioxidant activity [abstract]. 9th International Conference on Alzheimer's Disease and Related Disorders, 17-22 July 2004; Philadelphia :P4-398.
157. Lewy AJ, Ahmed S, Jackson JM, Sack RL: Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 1992, 9:380-392.
158. Lewy AJ, Ahmed S, Sack RL: Phase shifting the human circadian clock using melatonin. Behav Brain Res 1996, 73:131-134.
159. Sulli A, Maestroni GJ, Villaggio B, Hertens E, Craviotto C, Pizzorni C, Briata M, Seriolo B, Cutolo M: Melatonin serum levels in rheumatoid arthritis. Ann NY Acad Sci 2002, 966:276-283.
160. Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, Buijs RM: Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004, 43:192-197.
161. Lusardi P, Piazza E, Fogari R: Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study. Br J Clin Pharmacol 2000, 49:423-427.
162. Escames G, Khaldy H, León J, González L, Acuña-Castroviejo D: Changes in iNOS activity, oxidative stress and melatonin levels in hypertensive patients treated with lacidipine. J Hypertens 2004, 22:629-635.